"There has to be more news about the next step of development."
Well this is the bit I don't really get. As far as I have researched, Remdesivir is under patent protection. So they would need to be working with Gilead on this product otherwise it would be pointless. So have they left it to the investor to put two and two together or will Gilead make an announcement themselves given it would allow mass distribution of their product or have Starpharma just played in their lab and are hoping to get a phone call from Gilead? The only 3 options my little brain can think of.
So why not spell out to investors the next steps in their announcement rather than have them guessing?
Ann: SPL creates slow release soluble DEP remdesivir nanoparticle, page-87
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(0.51%) |
Mkt cap ! $41.52M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $9.732K | 98.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 384741 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 493798 | 2 |
View Market Depth
| Last trade - 15.24pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |